Rusan Pharma’s API Plant in Ankleshwar Receives USFDA GMP Approval
Rusan Pharma's new facility in India will enhance its global capabilities, expand its API product portfolio, and increase its presence in the US pharmaceutical sector.
Drug Manufacturers
Drug development costs predicted to soar as BIOSECURE Act gains momentum
German CDMO outlays $980m on GLP-1 manufacturing expansion
Join the revolution of on-dose authentication
Blockbuster deals are shaping key player CMOs despite 31% drop in M&A
Emergent to sell US sterile manufacturing facility to Bora
Johnson & Johnson seeks FDA approval for Tremfya for Crohn’s disease
How to streamline your pharma mass production by leveraging the Körber Ecosystem
